Analysts expect over 2018 decreasing revenue Novozymes

Tomorrow the Danish company Novozymes will publish its past quarter's results. Over the current book year the total revenue will be 14,45 billion Danish Krone (consensus estimates). This is slightly lower than 2017's revenue of 14,53 billion Danish Krone.

Historical revenues and results Novozymes plus estimates 2018

equity research

The analysts expect for 2018 a net profit of 3,21 billion Danish Krone. For this year the consensus of Novozymes 's result per share is a profit of 10,97 Danish Krone. Based on this the price/earnings-ratio is 31,14.

Per share the analysts are expecting a dividend of 4,99 Danish Krone per share. The dividend yield is then 1,46 percent. The average dividend yield of the chemical companies is a limited 1 percent.

Novozymes 's market capitalization is based on the number of outstanding shares around 83,31 billion Danish Krone.

At 16.59 the stock trades 1,58 percent higher at 341,6 Danish Krone.

Historical stock prices Novozymes past 10 years

equity research novozymes

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.